Polyclonal Antibody to Fibulin 3 (FBLN3)
EFEMP1; DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; EGF-Containing Fibulin-Like Extracellular Matrix Protein 1; Fibrillin-Like; Extracellular protein S1-5
- Product No.PAF422Mu02
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- SourcePolyclonal antibody preparation
- HostRabbit
- Potencyn/a
- Ig Type IgG
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Immunogen n/a
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
- Concentration500µg/mL
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IP.
 If the antibody is used in flow cytometry, please check FCM antibodies.
- Downloadn/a
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
    
                                    US$ 108 
            
                
                        US$ 252 
                                        US$ 360 
                                        US$ 900 
                                        US$ 3600 
                            
 For more details, please contact local distributors!
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against FBLN3. It has been selected for its ability to recognize FBLN3 in immunohistochemical staining and western blotting.
USAGE
        
                        Western blotting: 0.2-2µg/mL;1:250-2500
                        
 Immunohistochemistry: 5-20µg/mL;1:25-100
                        
 Immunocytochemistry: 5-20µg/mL;1:25-100
                        
 Optimal working dilutions must be determined by end user.
                        
    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                     Antibody Labeling Customized Service Antibody Labeling Customized Service
- 
                     Protein A/G Purification Column Protein A/G Purification Column
- 
                     Staining Solution for Cells and Tissue Staining Solution for Cells and Tissue
- 
                     Positive Control  for Antibody Positive Control  for Antibody
- 
                     Tissue/Sections Customized Service Tissue/Sections Customized Service
- 
                     Phosphorylated Antibody Customized Service Phosphorylated Antibody Customized Service
- 
                     Western Blot (WB) Experiment Service Western Blot (WB) Experiment Service
- 
                     Immunohistochemistry (IHC) Experiment Service Immunohistochemistry (IHC) Experiment Service
- 
                     Immunocytochemistry (ICC) Experiment Service Immunocytochemistry (ICC) Experiment Service
- 
                     Flow Cytometry (FCM) Experiment Service Flow Cytometry (FCM) Experiment Service
- 
                     Immunoprecipitation (IP) Experiment Service Immunoprecipitation (IP) Experiment Service
- 
                     Immunofluorescence (IF) Experiment Service Immunofluorescence (IF) Experiment Service
- 
                     Buffer Buffer
- 
                     DAB Chromogen Kit DAB Chromogen Kit
- 
                     SABC Kit SABC Kit
- 
                     Long-arm Biotin Labeling Kit Long-arm Biotin Labeling Kit
- 
                     Real Time PCR Experimental Service Real Time PCR Experimental Service
| Magazine | Citations | 
| 1 | Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma PubMed: PMC3761217 | 
| Anticancer Res. | YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. Pubmed: 24324091 | 
| Oncology Reports | Role of fibulin-3 in lung cancer: In vivo and in vitro analyses Spandidos-publications: Source | 
| Current Pulmonology Reports | Discovery of new biomarkers for malignant mesothelioma Springer:Source | 
| United States Patent Application 20140378336 | DIAGNOSIS OF CELL PROLIFERATIVE DISEASES Freepatentsonline:Source | 
| Thorax. | Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma Pubmed:Pmc4174124 | 
| Egyptian Journal of Chest Diseases and Tuberculosis | Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions Pubmed:23050525 | 
| Radiol Oncol | Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma PubMed: 26401134 | 
| British Journal of Cancer | Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis PubMed: 26263483 | 
| J Thorac Oncol. | Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. Pubmed:26903362 | 
| BMJ Open | Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study pubmed:27884852 | 
| 25 | HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients pubmed:26733616 | 
| BMJ Journals | Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational … e013324.abstract | 
| Anticancer Res. | Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma. pubmed:28314308 | 
| Dis Markers. | A Novel Panel of Serum Biomarkers for MPM Diagnosis. pubmed:28348450 | 
| The Knee | Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study pubmed:29195846 | 
| Disease markers | Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population pubmed:29200597 | 
| Molecular Medicine Reports | Placental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes Pubmed:29749501 | 
| Oncotarget | The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion Pubmed:30046386 | 
| Advances in Clinical and Experimental Medicine | Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with … 68362.pdf | 
| PLoS One | Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals Pubmed: 30946771 | 
| Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) | 
| RPF422Mu01 | Recombinant Fibulin 3 (FBLN3) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPF422Mu02 | Recombinant Fibulin 3 (FBLN3) | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAF422Mu01 | Polyclonal Antibody to Fibulin 3 (FBLN3) | WB; IHC; ICC; IP. | 
| PAF422Mu02 | Polyclonal Antibody to Fibulin 3 (FBLN3) | WB; IHC; ICC; IP. | 
| SEF422Mu | ELISA Kit for Fibulin 3 (FBLN3) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMF422Mu | Multiplex Assay Kit for Fibulin 3 (FBLN3) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. | 
 
         

 
    